PPI vs. teprenone in preventing recurrence of ulcers during low-dose aspirin.
Division of Gastroenterology, University of Tennessee Health Science Center, Memphis, TN, USA. chowden@uthsc.edu.
C W
CW
Howden
D000897:Anti-Ulcer Agents / Q000627:therapeutic use*; D001241:Aspirin / Q000009:adverse effects*; D004381:Duodenal Ulcer / Q000188:drug therapy*; D005260:Female; D005343:Fibrinolytic Agents / Q000009:adverse effects*; D006801:Humans; D008297:Male; D064750:Rabeprazole / Q000627:therapeutic use*; D013276:Stomach Ulcer / Q000188:drug therapy*
D000897:Anti-Ulcer Agents; D005343:Fibrinolytic Agents; D064750:Rabeprazole; D001241:Aspirin